切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - HBV Proteases - Dipeptidyl-peptidase II - HIV-1 reverse transcriptase - Topoisomerases

19件产品中的 1-10

页面
每页
清除全部
  1. (S)-10-Hydroxycamptothecin
    B4745 (S)-10-Hydroxycamptothecin
    中文名: 羟喜树碱
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.8 mg/mL
      insoluble in H2O
  2. UAMC 00039 dihydrochloride
    B5780 UAMC 00039 dihydrochloride
    Target: Dipeptidyl-peptidase II
    Summary: 二肽基肽酶II(DPP-II)抑制剂
      ≥133.6 mg/mL
      ≥94.6 mg/mL
  3. Ellipticine
    B7382 Ellipticine
    中文名: 玫瑰树碱,椭圆玫瑰树碱
    Target: Topoisomerases
    Summary: DNA拓扑异构酶II抑制剂
      ≥24.6 mg/mL
      insoluble in H2O
  4. Pirarubicin
    B2295 Pirarubicin
     1 Citation
    中文名: 吡柔比星
    Target: Topoisomerases
    Summary: 拓扑异构酶II抑制剂,蒽环类抗生素
      ≥7.65 mg/mL
      insoluble in H2O
  5. Norfloxacin
    B1801 Norfloxacin
    中文名: 诺氟沙星
    Target: Topoisomerases
    Summary: 拓扑异构酶抑制剂
      insoluble in DMSO
      insoluble in H2O
  6. Irinotecan HCl Trihydrate
    B2293 Irinotecan HCl Trihydrate
    中文名: 盐酸依立替康三水合物
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.1 mg/mL
      ≥2.5 mg/mL
  7. Efavirenz
    B1119 Efavirenz
    中文名: 依法韦仑
    Target: HIV-1 reverse transcriptase
    Summary: 逆转录酶抑制剂
      ≥15.55 mg/mL
      insoluble in H2O
  8. Beta-Lapachone
    B2290 Beta-Lapachone
    中文名: β-拉帕醌
    Target: Topoisomerases
    Summary: 选择性DNA拓扑异构酶I抑制剂
      ≥10.85 mg/mL
      insoluble in H2O
  9. Clinafloxacin CI96 AM1091
    A8400 Clinafloxacin CI96 AM1091
    中文名: 克林沙星
    Target: Topoisomerases
    Summary: 拓扑异构酶抑制剂
      ≥3.66 mg/mL
      insoluble in H2O
  10. Lamivudine
    A8458 Lamivudine
    中文名: 拉米夫定,拉美呋定,拉米呋啶
    Target: HBV Proteases
    Summary: 核苷类似物逆转录酶抑制剂
      ≥10.5 mg/mL
      ≥89.4 mg/mL

19件产品中的 1-10

页面
每页